Inventor
FU JIPING
US35 patents
⚠️ This page may combine multiple inventors who share the name “FU JIPING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
12 patentsUS9845325B2Dec 19, 2017
Tetracyclic pyridone compounds as antivirals
NOVARTIS AG24 citations93
US10301312B2May 28, 2019
Fused indazole pyridone compounds as antivirals
NOVARTIS AG7 citations82
US8008263B2Aug 30, 2011
Organic compounds and their uses
NOVARTIS AG12 citations82
US10093673B2Oct 9, 2018
Tetracyclic pyridone compounds as antivirals
NOVARTIS AG3 citations72
US7825152B2Nov 2, 2010
Organic compounds and their uses
NOVARTIS AG7 citations72
US11234977B2Feb 1, 2022
Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
NOVARTIS AG1 citations61
US10975078B2Apr 13, 2021
Fused indazole pyridone compounds as antivirals
NOVARTIS AG0 citations61
US9815804B2Nov 14, 2017
Isoxazole hydroxamic acid compounds as LpxC inhibitors
NOVARTIS AG1 citations61
US10029994B2Jul 24, 2018
Isoxazole hydroxamic acid compounds as LpxC inhibitors
NOVARTIS AG0 citations51
US9718792B2Aug 1, 2017
Isoxazoline hydroxamic acid derivatives as LpxC inhibitors
NOVARTIS AG1 citations51
US10071973B2Sep 11, 2018
Crystalline isoxazole hydroxamic acid compounds
NOVARTIS AG0 citations50
US9566312B2Feb 14, 2017
Cyclic peptides and use as medicines
NOVARTIS AG0 citations50
NIKANG THERAPEUTICS INC
12 patentsUS11267782B2Mar 8, 2022
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
NIKANG THERAPEUTICS INC6 citations85
US11753366B2Sep 12, 2023
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
NIKANG THERAPEUTICS INC3 citations73
US11518772B2Dec 6, 2022
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
NIKANG THERAPEUTICS INC1 citations73
US11459340B2Oct 4, 2022
Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
NIKANG THERAPEUTICS INC1 citations73
US11420936B2Aug 23, 2022
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
NIKANG THERAPEUTICS INC2 citations73
US11634382B2Apr 25, 2023
Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
NIKANG THERAPEUTICS INC2 citations70
US12391642B2Aug 19, 2025
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
NIKANG THERAPEUTICS INC0 citations62
US12264167B2Apr 1, 2025
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
NIKANG THERAPEUTICS INC0 citations62
US12415779B2Sep 16, 2025
Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof
NIKANG THERAPEUTICS INC0 citations60
US12435034B2Oct 7, 2025
Process of preparing 3-fluoro-5(((1R,2AR)-3,3,4,4-tetrafluoro-1,2A-dihydroxy-2,2A,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile
NIKANG THERAPEUTICS INC0 citations59
US12171741B2Dec 24, 2024
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
NIKANG THERAPEUTICS INC0 citations52
US12077506B2Sep 3, 2024
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
NIKANG THERAPEUTICS INC0 citations52